• Follow
  • Follow
  • Follow
  • Follow
  • Platform
  • Solutions
    • AlertWatch:OR
    • AlertWatch:OB
    • AlertWatch:AC
  • Research
  • About
    • Blog
  • Try the Demo
  • Contact

AlertWatch Selected as Semi-Finalist in the Accelerate Michigan Innovation Competition

by alertwatch-admin | Sep 17, 2014 | Press Release

FOR IMMEDIATE RELEASE — September 17, 2014, Ann Arbor, Michigan — AlertWatch is proud to announce that it has been chosen as a semi-finalist in the 2014 Accelerate Michigan Innovation Competition. The annual event brings over 50 Michigan startups together...

U-M Startup AlertWatch Gains FDA Clearance to Sell Patient Monitoring Software

by alertwatch-admin | Feb 11, 2014 | Press Release

FOR IMMEDIATE RELEASE–February 11, 2014, Ann Arbor, MI–AlertWatch Inc., a University of Michigan startup, gained U.S. Food and Drug Administration clearance on Friday to sell its patient monitoring software to hospitals. AlertWatch helps anesthesia...

AlertWatch Granted Second Patent for OR Patient Monitoring System, Begins ICU Testing

by alertwatch-admin | Aug 19, 2013 | Press Release

FOR IMMEDIATE RELEASE ⎯ August 19, 2013, Ann Arbor, Michigan ⎯ AlertWatch, Inc.’s patient monitoring system just received patent #8,454,507 from the U.S. Patent and Trademark Office. The software system supports the delivery of patient care by providing an intuitive...

Recent Posts

  • Welcome to the new AlertWatch website! July 30, 2021
  • Clinical Computer Systems, Inc. announces a reseller agreement with AlertWatch December 26, 2020
  • Anesthesia Staffing Shortage – Winter is Coming November 20, 2019
  • Joint Commission urges action on maternal safety September 11, 2019
  • AlertWatch announces strategic relationship with Qualcomm Life February 28, 2018

PLATFORM
RESEARCH
ABOUT
BLOG

CONTACT
DEMO
SERVICE LEVELS

  • Follow
  • Follow
  • Follow
  • Follow

AlertWatch:OR
AlertWatch:OB
AlertWatch:AC

AlertWatch:OR, AlertWatch:AC and AlertWatch:OB are FDA 510(k)-cleared for sale in the United States, andare intended for use by clinicians for secondary monitoring of patients. AlertWatch accomplishes this by aggregating data from a multitude of sources and displaying them at a central location. Once alerted, the clinician must refer to the primary monitoring device before making a clinical decision.

© Copyright 2021 AlertWatch. All rights reserved.